The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Clinical trial NCT02965859 · UNKNOWN
Trial details
- NCT number
- NCT02965859
- Sponsor
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.